Ocrelizumab Alters Cytotoxic Lymphocyte Function While Reducing EBV-Specific CD8+ T-Cell Proliferation in Patients With Multiple Sclerosis
Article in Neurology Neuroimmunology & Neuroinflammation (April 2024)
The most recent citing publications are shown below. View all 78 publications that cite this research output on Dimensions.
Insights into the interplay between Epstein‐Barr virus (EBV) and multiple sclerosis (MS): A state‐of‐the‐art review and implications for vaccine development
Article in Health Science Reports (February 2024)
Diversification and expansion of the EBV-reactive cytotoxic T lymphocyte repertoire following autologous haematopoietic stem cell transplant for multiple sclerosis
Article in Clinical Immunology (July 2023)